Stockholm's stock market experienced mixed activity early in the week, with the OMXS30 index declining 0.6% on June 2 amid concerns over new steel tariffs, despite gains in companies like SSAB and Saab. The industrial sector faced pressure, while SSAB rose on news related to tariff threats. In corporate developments, AMF Pension and Lannebo Fonder, owning a combined 7.1% stake, rejected EQT's takeover bid for the software company Fortnox, citing high valuation multiples. Swedbank Robur, however, indicated it would accept the offer. The bid's future remains uncertain as further shareholder resistance could derail the acquisition. On June 3, the OMXS30 edged up 0.3%, with gains in Bioarctic, Saab, and Klarna's CEO's investment firm. Capital market activities included Ossdsign's directed share issue of 158 million SEK at a 3.6% discount to the recent volume-weighted average price, and Logistea's directed new share issue raising 500 million SEK. Sweco launched a takeover bid for the technical consultancy Projektengagemang at a 117% premium, offering 15 SEK per share, which led to a sharp rise in Projektengagemang's stock. Pharmaceutical company Camurus surged over 30% following a multi-billion SEK collaboration agreement with U.S.-based Eli Lilly, a deal viewed as timely but with some uncertainties. Separately, Swedbank announced a target return of at least 15% and plans to end its hiring freeze. Analysts noted growth potential for Nordnet outside Sweden, contrasting with Avanza's domestic market focus.